Consultants  /  Dr. Bhuvan Chugh
Oncology consultant profile

Dr. Bhuvan Chugh

Medical Oncology

Max Super Specialty Hospital Gurgaon →

OncologyBreast CancerLung CancerMolecular Oncology and Precision Medicine
Professional overview

About Dr. Bhuvan Chugh

Dr Bhuvan Chugh is a Medical Oncologist with rich experience in the treatment of solid organ cancers. He has a special interest in breast, thoracic, head & neck and hepato-billiary malignancies. He is the convener for the molecular tumour board at Max Saket and Gurgaon and has a keen interest in precision medicine. He has been an active part of the faculty both in terms of clinical and research work. Have co-authored many chapters, papers & abstracts in various national and international journals and conferences.

Clinical focus

Areas of expertise

  • Breast Cancer
  • Lung Cancer
  • Molecular Oncology and Precision Medicine
  • Hepatobiliary Cancer
Training and experience

Qualifications

  • DNB Medical Oncology - Medanta, the Medicity, Gurgaon, Haryana (NBE)
  • DNB General Medicine - (Army Base Hospital, Delhi Cantt, Delhi (NBE)
  • MBBS - Rajiv Gandhi University of Health Sciences, Karnataka
Research

Publications

  • Chugh, B. and Vaid, A K. 2020. ‘Key Takeaways from International Guidelines on Gastric Cancer’. Gastric Cancer. Springer Healthcare Education
  • Clinico-hematologic and cytogenetic profile in a rare case of pure erythroid leukaemia; Annals of Haematology 98(3); March 2019.
  • Myelodysplastic syndromes: Where do we stand? Asian Journal of Oncology. April 2016.
  • Outcomes of patients presenting with acute coronary syndrome with vitamin D deficiency. Indian Heart Journal. November 2014.

PRESENTATIONS

  • Abstract Publication in BTG2018, 9th International Hematologic Malignancies Conference held in Seoul, South Korea from March 29-31, 2018.
  • A Prospective Study of Clinico-pathological features, Prognostic factors, and Response rates in Advanced Non-small Cell Lung Cancer Patients Eligible for Chemotherapy - A Single Centre Experience at 37th ICON New Delhi. 2017
  • A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre; Blood 134(Supplement_1):5559-5559; November 2019
  • Speaking engagements in various national level conferences
Need help deciding?

Request coordinated guidance for your case.

Share your reports to understand suitable consultants, hospitals and next steps.

Request guidance →